Midbrain-Hindbrain Involvement in Septo-Optic Dysplasia

REFERENCES

1. 1.↵
   1. Webb EA,
   2. Dattani MT

   . Septo-optic dysplasia. Eur J Hum Genet 2010;18:393–97

   CrossRefPubMed
2. 2.↵
   1. McCabe MJ,
   2. Gaston-Massuet C,
   3. Tziaferi V,
   4. et al

   . Novel FGF8 mutations associated with recessive holoprosencephaly, craniofacial defects, and hypothalamo-pituitary dysfunction. J Clin Endocrinol Metab 2011;96:1709–18

   CrossRef
3. 3.↵
   1. McCabe MJ,
   2. Alatzoglou KS,
   3. Dattani MT

   . Septo-optic dysplasia and other midline defects: the role of transcription factors: HESX1 and beyond. Best Pract Res Clin Endocrinol Metab 2011;25:115–24

   CrossRef
4. 4.↵
   1. Raivio T,
   2. Avbelj M,
   3. McCabe MJ,
   4. et al

   . Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia. J Clin Endocrinol Metab 2012;97:694–99

   CrossRef
5. 5.↵
   1. Signorini SG,
   2. Decio A,
   3. Fedeli C,
   4. et al

   . Septo-optic dysplasia in childhood: the neurological, cognitive and neuro-ophthalmological perspective. Dev Med Child Neurol 2012;54:1018–24

   CrossRefPubMed
6. 6.↵
   1. Broccoli V,
   2. Boncinelli E,
   3. Wurst W

   . The caudal limit of Otx2 expression positions the isthmic organizer. Nature 1999;401:164–68

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Millet S,
   2. Campbell K,
   3. Epstein DJ,
   4. et al

   . A role for Gbx2 in repression of Otx2 and positioning the mid/hindbrain organizer. Nature 1999;401:161–64

   CrossRefPubMed
8. 8.↵
   1. Sato T,
   2. Joyner AL

   . The duration of Fgf8 isthmic organizer expression is key to patterning different tectal-isthmo-cerebellum structures. Development 2009;136:3617–26

   Abstract/FREE Full Text
9. 9.↵
   1. Beby F,
   2. Lamonerie T

   . The homeobox gene Otx2 in development and disease. Exp Eye Res 2013;111:9–16

   CrossRefPubMed
10. 10.↵
    1. Rumboldt Z,
    2. Castillo M,
    3. Huang B,
    4. Rossi A

    1. Severino M

    . Septo-optic dysplasia. In: Rumboldt Z, Castillo M, Huang B, Rossi A, eds. Brain Imaging With MRI and CT: An Image Pattern Approach. New York: Cambridge University Press; 2012:146–47
11. 11.↵
    1. Belhocine O,
    2. André C,
    3. Kalifa G,
    4. et al

    . Does asymptomatic septal agenesis exist? A review of 34 cases. Pediatr Radiol 2005;35:410–18

    CrossRefPubMed
12. 12.↵
    1. Ragge NK,
    2. Brown AG,
    3. Poloschek CM,
    4. et al

    . Heterozygous mutations of OTX2 cause severe ocular malformations. Am J Hum Genet 2005;76:1008–22

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Levine LM,
    2. Bhatti MT,
    3. Mancuso AA

    . Septo-optic dysplasia with olfactory tract and bulb hypoplasia. Journal of AAPOS 2001;5:398–99

    CrossRefPubMed
14. 14.↵
    1. Barkovich AJ,
    2. Fram EK,
    3. Norman D

    . Septo-optic dysplasia: MR imaging. Radiology 1989;171:189–92

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Miller SP,
    2. Shevell MI,
    3. Patenaude Y,
    4. et al

    . Septo-optic dysplasia plus: a spectrum of malformations of cortical development. Neurology 2000;54:1701–03

    CrossRef
16. 16.↵
    1. Riedl S,
    2. Vosahlo J,
    3. Battelino T,
    4. et al

    . Refining clinical phenotypes in septo-optic dysplasia based on MRI findings. Eur J Pediatr 2008;167:1269–76

    CrossRefPubMed
17. 17.↵
    1. Namavar Y,
    2. Barth PG,
    3. Poll-The BT,
    4. et al

    . Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia. Orphanet J Rare Dis 2011;12:6:50
18. 18.↵
    1. Rossi A,
    2. Catala M,
    3. Biancheri R,
    4. et al

    . MR imaging of brain-stem hypoplasia in horizontal gaze palsy with progressive scoliosis. AJNR Am J Neuroradiol 2004;25:1046–48

    Abstract/FREE Full Text
19. 19.↵
    1. Briguglio M,
    2. Pinelli L,
    3. Giordano L,
    4. et al

    . Pontine tegmental cap dysplasia: developmental and cognitive outcome in three adolescent patients. Orphanet J Rare Dis 2011;6:36

    CrossRefPubMed
20. 20.↵
    1. Barkovich AJ,
    2. Millen KJ,
    3. Dobyns WB

    . A developmental classification of malformations of the brainstem. Ann Neurol 2007;62:625–39

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Barkovich AJ,
    2. Millen KJ,
    3. Dobyns WB

    . A developmental and genetic classification for midbrain-hindbrain malformations. Brain 2009;132:3199–230

    Abstract/FREE Full Text
22. 22.↵
    1. Clement E,
    2. Mercuri E,
    3. Godfrey C,
    4. et al

    . Brain involvement in muscular dystrophies with defective dystroglycan glycosylation. Ann Neurol 2008;64:573–82

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Jissendi-Tchofo P,
    2. Kara S,
    3. Barkovich AJ

    . Midbrain-hindbrain involvement in lissencephalies. Neurology 2009;72:410–18

    CrossRef
24. 24.↵
    1. Soto-Ares G,
    2. Joyes B,
    3. Lemaître MP,
    4. et al

    . MRI in children with mental retardation. Pediatr Radiol 2003;33:334–45

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Matsuo I,
    2. Kuratani S,
    3. Kimura C,
    4. et al

    . Mouse Otx2 functions in the formation and patterning of rostral head. Genes Dev 1995;9:2646–58

    Abstract/FREE Full Text
26. 26.↵
    1. Acampora D,
    2. Gulisano M,
    3. Broccoli V,
    4. et al

    . Otx genes in brain morphogenesis. Prog Neurobiol 2001;64:69–95

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Nakamura H,
    2. Watanabe Y

    . Isthmus organizer and regionalization of the mesencephalon and metencephalon. Int J Dev Biol 2005;49:231–35

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Simeone A,
    2. Acampora D,
    3. Gulisano M,
    4. et al

    . Nested expression domains of four homeobox genes in developing rostral brain. Nature 1992;358:687–90

    CrossRefPubMed
29. 29.↵
    1. Larsen KB,
    2. Lutterodt MC,
    3. Møllgård K,
    4. et al

    . Expression of the homeobox genes OTX2 and OTX1 in the early developing human brain. J Histochem Cytochem 2010;58:669–78

    Abstract/FREE Full Text
30. 30.↵
    1. Liu A,
    2. Joyner AL

    . EN and GBX2 play essential roles downstream of FGF8 in patterning the mouse mid/hindbrain region. Development 2001;128:181–91

    Abstract
31. 31.↵
    1. Nishida A,
    2. Furukawa A,
    3. Koike C,
    4. et al

    . Otx2 homeobox gene controls retinal photoreceptor cell fate and pineal gland development. Nat Neurosci 2003;6:1255–63

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Abouzeid H,
    2. Youssef MA,
    3. ElShakankiri N,
    4. et al

    . PAX6 aniridia and interhemispheric brain anomalies. Mol Vis 2009;15:2074–83

    PubMed
33. 33.↵
    1. Bamiou DE,
    2. Free SL,
    3. Sisodiya SM,
    4. et al

    . Auditory interhemispheric transfer deficits, hearing difficulties, and brain magnetic resonance imaging abnormalities in children with congenital aniridia due to PAX6 mutations. Arch Pediatr Adolesc Med 2007;161:463–69

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Webb EA,
    2. O'Reilly MA,
    3. Orgill J,
    4. et al

    . Rest-activity disturbances in children with septo-optic dysplasia characterized by actigraphy and 24-hour plasma melatonin profiles. J Clin Endocrinol Metab 2010;95:198–203

    CrossRef
35. 35.↵
    1. Ashkenazi-Hoffnung L,
    2. Lebenthal Y,
    3. Wyatt AW,
    4. et al

    . A novel loss-of-function mutation in OTX2 in a patient with anophthalmia and isolated growth hormone deficiency. Hum Genet 2010;127:721–29

    CrossRefPubMed
36. 36.↵
    1. Tajima T,
    2. Ohtake A,
    3. Hoshino M,
    4. et al

    . OTX2 loss of function mutation causes anophthalmia and combined pituitary hormone deficiency with a small anterior and ectopic posterior pituitary. J Clin Endocrinol Metab 2009;94:314–19

    CrossRefPubMed
37. 37.↵
    1. Wyatt A,
    2. Bakrania P,
    3. Bunyan DJ,
    4. et al

    . Novel heterozygous OTX2 mutations and whole gene deletions in anophthalmia, microphthalmia and coloboma. Hum Mutat 2008;29:278–83

    CrossRef
38. 38.↵
    1. Schilter KF,
    2. Schneider A,
    3. Bardakjian T,
    4. et al

    . OTX2 microphthalmia syndrome: four novel mutations and delineation of a phenotype. Clin Genet 2011;79:158–68

    CrossRefPubMed
39. 39.↵
    1. Elliott J,
    2. Maltby EL,
    3. Reynolds B

    . Acase of deletion 14(q22.1->q22.3) associated with anophthalmia and pituitary abnormalities. J Med Genet 1993;30:251–52

    Abstract/FREE Full Text
40. 40.↵
    1. Lemyre E,
    2. Lemieux N,
    3. Decarie JC,
    4. et al

    . Del(14)(q22.1q23.2) in a patient with anophthalmia and pituitary hypoplasia. Am J Med Genet 1998;77:162–65

    CrossRefPubMedWeb of Science
41. 41.↵
    1. Nolen LD,
    2. Amor D,
    3. Haywood A,
    4. et al

    . Deletion at 14q22–23 indicates a contiguous gene syndrome comprising anophthalmia, pituitary hypoplasia, and ear anomalies. Am J Med Genet A 2006;140:1711–18

    PubMed
42. 42.↵
    1. Hayashi S,
    2. Okamoto N,
    3. Makita Y,
    4. et al

    . Heterozygous deletion at 14q22.1-q22.3 including the BMP4 gene in a patient with psychomotor retardation, congenital corneal opacity and feet polysyndactyly. Am J Med Genet A 2008;146:2905–10
43. 43.↵
    1. Bakrania P,
    2. Efthymiou M,
    3. Klein JC,
    4. et al

    . Mutations in BMP4 cause eye, brain, and digit developmental anomalies: overlap between the BMP4 and hedgehog signaling pathways. Am J Hum Genet 2008;82:304–19

    CrossRefPubMedWeb of Science